Mode
Text Size
Log in / Sign up

Peripheral nerve stimulation improves tremor severity and functional disability in patients with essential tremorNerve stimulation shows promise for managing essential tremor symptoms

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider peripheral nerve stimulation as a non-invasive option for medication-refractory essential tremor.

This meta-analysis evaluated the efficacy of peripheral nerve stimulation (PNS), including TAPS and TPNS, for managing essential tremor in a population of 2541 patients. The analysis compared PNS against sham-controlled and single-arm pre-post designs to assess tremor severity and functional disability.

Sham-controlled analyses revealed statistically significant improvements in TETRAS performance scale scores (MD = -1.00, p = 0.002) and BF-ADL scores (MD = -1.69, p < 0.0001). Single-arm pre-post analyses also showed significant improvement in BF-ADL scores (MD = -3.22, p < 0.0001). However, results for total TETRAS were not statistically significant (p = 0.16), and tremor amplitude results were inconsistent due to high heterogeneity (I up to 94%).

Safety data indicated a favorable profile with mostly mild and transient adverse events, such as skin irritation (7.88%), and no serious adverse events were reported. The authors noted high heterogeneity in tremor amplitude and total TETRAS outcomes due to differences in assessment timing. These findings suggest PNS may be a viable non-invasive, on-demand therapeutic option for patients with medication-refractory tremor or those unsuitable for surgery.

How this fits prior evidence

This meta-analysis extends the finding that peripheral nerve stimulation significantly reduces tremor intensity and functional disability in essential tremor. It specifically quantifies the improvement in functional disability (BF-ADL) and tremor severity (TETRAS performance scale) using a sample of 2541 patients. The results reinforce the role of PNS as a non-invasive alternative to other interventions like botulinum toxin type A or Vim-targeted tremor surgery.

Living with an essential tremor can make daily tasks, from holding a cup to buttoning a shirt, feel like a constant struggle. For people who cannot take medication or are not candidates for surgery, finding a reliable way to manage these shakes is vital. Recent data suggests that peripheral nerve stimulation, a non-invasive method, may offer a helpful option.

Researchers looked at data from over 2,500 patients to see how this stimulation affected their symptoms. The results showed that patients using the treatment saw significant improvements in their tremor scores and their ability to perform daily activities. While some measures like total tremor scores were less consistent, the focus on daily function showed clear progress.

Safety is a major factor for patients seeking new options. The study found that the treatment was well tolerated, with only mild and temporary side effects like skin irritation. While the results for some specific measurements were mixed due to differences in how they were timed, the overall evidence suggests this is a viable option for those seeking non-invasive relief.

What this means for you:
Non-invasive nerve stimulation can improve daily function and reduce tremor severity for some patients.

Common questions

Is nerve stimulation safe for people with tremors?

Yes, the treatment showed a favorable safety profile. Most side effects were mild and temporary, with skin irritation being the most common issue reported by about 7.88% of people. No serious adverse events were reported in the data.

How does this treatment help with daily activities?

The study found that patients who received the stimulation showed significant improvements in scores related to their ability to perform daily activities. This makes it a potential option for those who need a non-invasive way to manage their symptoms.

Who is this treatment best for?

This option is particularly useful for patients whose tremors do not respond well to medication or for those who are not suitable candidates for surgery. It can be used as an on-demand or additional treatment.

Study Details

Study typeMeta analysis
Sample sizen = 2,541
EvidenceLevel 1
PublishedOct 2026
View Original Abstract ↓
BACKGROUND: Essential tremor (ET) is the most prevalent movement disorder worldwide. There are limited current pharmacological therapies, and their side effects often preclude adequate doses. Surgical therapies, such as Deep Brain Stimulation (DBS) and Focused Ultrasound (FUS), are reserved for patients with tremor that debilitates activities of daily living (ADLs). Peripheral nerve stimulation (PNS), including transcutaneous afferent patterned stimulation (TAPS) and transcutaneous peripheral nerve stimulation (TPNS), has emerged as a promising non-invasive neuromodulatory approach for many patients with intermediate symptoms. METHODS: A systematic review and meta-analysis following PRISMA 2020 guidelines was conducted, with searches across PubMed, Scopus, Cochrane, and Web of Science. Studies enrolling patients with ET assessing TAPS and TPNS were included. Primary outcomes were tremor severity (TETRAS performance scale, total TETRAS) and tremor amplitude. Secondary outcomes included functional disability (BF-ADL, TETRAS-mADL) and safety. RESULTS: Nineteen studies (2,541 patients) were included. Sham-controlled analyses showed statistically significant improvement in TETRAS performance scale scores (MD = - 1.00; p = 0.002; I = 0%). BF-ADL scores improved significantly in sham-controlled analyses (MD = - 1.69; p < 0.0001) and single-arm pre-post analyses (MD = - 3.22; p < 0.0001). Tremor amplitude and total TETRAS outcomes were inconsistent, with high heterogeneity (I up to 94%) driven mainly by differences in assessment timing; the pooled total TETRAS estimate was not statistically significant (p = 0.16). Adverse events were mostly mild and transient; skin irritation was the most frequently reported (7.88%), and no serious adverse events were attributed to the intervention. CONCLUSIONS: PNS consistently improved functional outcomes with a favorable safety profile in ET patients. These findings support PNS as a viable adjunctive or on-demand non-invasive therapeutic option, particularly for medication-refractory patients or those unsuitable for surgery.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.